Analysts consensus

Interparfums’ stock is covered by a number of brokerage firms, banks and financial institutions who regularly issue ratings and and publish research on the company for their clients. We in turn publish a summary of their recommendations when authorized by the authors and are committed to providing updates of all recommendations we receive.

Brokerage firm Analyst	Rating	Sales 2012 in €m	Sales 2013 in €m	EBIT 2012 in €m %CA	EBIT 2013 in €m %CA	Net earnings 2012 in €m %CA	Net earnings 2013 in €m %CA	Target Stock value in €	Last update on
Exane BNP PARIBAS Pierre Bernardin	Neutral	427.1	476.9	52.3 12.2%	58.4 12.2%	35.1 8.2%	39.0 8.2%	21.00	03/19/12
Gilbert Dupont Ning Godement	Buy	408.5	447.8	48.7 11.9%	54.2 12.1%	31.7 7.8%	35.8 8.0%	23.10	03/13/12
ID Midcaps Bruno Jehl	Buy	410.0	425.0	48.4 11.8%	51.0 12.0%	32.6 8.0%	35.0 8.2%	25.00	03/13/12
Natixis Pierre Tegner	Reduce	400.0	430.0	46.8 11.7%	53.3 12.4%	31.7 7.9%	35.8 8.3%	16.00	03/13/12
Oddo⁽¹⁾ Camille Damois-Gignoux	Neutral	420.0	464.0	50.0 11.9%	56.3 12.1%	32.7 7.8%	37.1 8.0%	22.00	03/14/12
Mean		413.1	448.7	49.2 11.9%	54.6 12.2%	32.8 7.9%	36.5 8.1%	21.42	03/12
Previous year mean		404.2	-	47.7 11.8%	-	31.9 7.9%	-	18.84	01/12
Previous year mean		397.2	-	47.2 11.9%	-	31.7 8.0%	-	25.20	11/11